An 'exciting' new Parkinson's disease drug promises to not only treat but to cure the condition at its root cause.Early clinical trials have shown that the drug, which works by using the patient's own immune system to fight the disease, is effective and well tolerated by patients with minimal, short-lived side effects.Parkinson's is a neurodegenerative disorder that affects over 8.5 million people worldwide, according to World Health Organization estimates.
They store these memories in the form of antibodies, which attach themselves to the surface molecules of disease-causing agents. Vaccines work by training our immune systems to recognize these surface molecules without having to actually get infected.Now, a new drug by the U.S. biotechnology company Vaxxinity promises to train our immune systems to fight these alpha-synuclein protein build ups in the brains of Parkinson's patients.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: ScienceDaily - 🏆 452. / 53 Read more »
Source: bbchealth - 🏆 143. / 63 Read more »